China’s CF PharmTech raises $50m in Series F round for inhalation products
CF PharmTech, a Chinese pharma company, has raised $50 million in a Series F financing round to accelerate the commercialization of its inhalation products. The investors who took part in the Series F funding round were BioTrack Capital, CICC Qichen, CICC Qide, Watson Investment, SAIC Hengxu, and GP M&A Fund. The existing investors of CF […]